Solid Biosciences Inc
SLDB
Get informed when a big investor buys or sells
+ FollowMarket Cap$571.86M
Close$
$0.44
93.5% downside
Current Fair Value
93.5% downsideOvervalued by 93.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $571.86 Million |
|---|---|
| Enterprise Value | $294.79 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.99 |
| Beta | 2.47 |
| Outstanding Shares | 109,811,461 |
Return
| Return on Equity | -51.26% |
|---|---|
| Return on Assets | -45.35% |
| Return on Invested Capital | -50.14% |
Valuation & Multiples
| P/E Ratio | -4.2 |
|---|---|
| PEG | -9.46 |
| Price to Sales | - |
| Price to Book Ratio | 2.28 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.5 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.45
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4733▲ 47.33% |
|---|---|
| Total Calls | 301,100▼ 50.16% |
| Total Puts | 142,500▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 105.24%▲ 19.06% |
|---|---|
| Total Invested | $717.40M▲ 56.31% |
| Investors Holding | 147▲ 18.00% |
ESG Score
No data